Abstract
Objective
To analyze the management, pathology and outcomes of Bosniak category IIF and III cystic renal lesions.
Methods
This retrospective study included 85 consecutive patients with Bosniak category IIF and III lesions, who were actively surveilled or surgically treated at three academic urology centers between 2003 and 2012. Outcomes of interest included the rates of cyst progression and pathology.
Results
Overall, 27 patients with Bosniak category IIF lesions were initially managed by active surveillance, from which eighteen (67 %) did not progress after a median interval of 64 months, while 9 (33 %) underwent surgery within a median interval of 18 months. There were 58 patients with Bosniak category III lesions, 54 (93 %) of which were managed by surgery. Compared with Bosniak category IIF, Bosniak category III lesions had more frequently proven RCC (64 vs. 30 %, p = 0.005). Of the tumors that underwent surgical extirpation, the T stage, grade (p = 0.65) and subtype distribution (p = 0.36) did not differ between the Bosniak categories. The majority of RCCs were low-stage and low-grade tumors. One patient developed a local recurrence. There were no RCC-specific deaths.
Conclusions
As only a minority of Bosniak IIF lesions are malignant and the majority are low-stage and low-grade tumors, initial active surveillance is the standard of care for these lesions. Progressive Bosniak IIF lesions may undergo later RCC treatment without seemingly loosing the window of cure. Bosniak III lesions harbor a high risk of malignancy and should be managed as solid renal tumors according to contemporary guidelines.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bosniak MA (1986) The current radiological approach to renal cysts. Radiology 158:1–10
Israel GM, Hindman N, Bosniak MA (2004) Evaluation of cystic renal masses: comparison of CT and MR imaging by using the Bosniak classification system. Radiology 231:365–371
Weibl P, Klatte T, Waldert M, Remzi M (2012) Complex renal cystic masses: current standards and controversies. Int Urol Nephrol 44:13–18
Smith AD, Remer EM, Cox KL, Lieber ML, Allen BC, Shah SN, Herts BR (2012) Bosniak category IIF and III cystic renal lesions: outcomes and associations. Radiology 262:152–160
Weibl P, Klatte T, Kollarik B, Waldert M, Schuller G, Geryk B, Remzi M (2011) Interpersonal variability and present diagnostic dilemmas in Bosniak classification system. Scand J Urol Nephrol 45:239–244
Park HS, Lee K, Moon KC (2011) Determination of the cutoff value of the proportion of cystic change for prognostic stratification of clear cell renal cell carcinoma. J Urol 186:423–429
Webster WS, Thompson RH, Cheville JC, Lohse CM, Blute ML, Leibovich BC (2007) Surgical resection provides excellent outcomes for patients with cystic clear cell renal cell carcinoma. Urology 70:900–904
El-Mokadem I, Budak M, Pillai S, Lang S, Doull R, Goodman C, Nabi G (2013) Progression, interobserver agreement, and malignancy rate in complex renal cysts (≥Bosniak category IIF). Urol Oncol. doi:10.1016/j.urolonc.2012.1008.1018
Graumann O, Osther SS, Karstoft J, Horlyck A, Osther PJ (2013) Evaluation of Bosniak category IIF complex renal cysts. Insights Imaging 4:471–480
Israel GM, Bosniak MA (2003) Follow-up CT of moderately complex cystic lesions of the kidney (Bosniak category IIF). AJR Am J Roentgenol 181:627–633
O’Malley RL, Godoy G, Hecht EM, Stifelman MD, Taneja SS (2009) Bosniak category IIF designation and surgery for complex renal cysts. J Urol 182:1091–1095
Ljungberg B, Cowan NC, Hanbury DC, Hora M, Kuczyk MA, Merseburger AS, Patard JJ, Mulders PF, Sinescu IC (2010) EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol 58:398–406
Campbell SC, Novick AC, Belldegrun A, Blute ML, Chow GK, Derweesh IH, Faraday MM, Kaouk JH, Leveillee RJ, Matin SF, Russo P, Uzzo RG (2009) Guideline for management of the clinical T1 renal mass. J Urol 182:1271–1279
Bosniak MA (2012) The Bosniak renal cyst classification: 25 years later. Radiology 262:781–785
Gabr AH, Gdor Y, Roberts WW, Wolf JS Jr (2009) Radiographic surveillance of minimally and moderately complex renal cysts. BJU Int 103:1116–1119
Allen BC, Chen MY, Childs DD, Zagoria RJ (2013) Imaging-guided radiofrequency ablation of cystic renal neoplasms. AJR Am J Roentgenol 200:1365–1369
Hora M, Hes O, Michal M, Boudova L, Chudacek Z, Kreuzberg B, Klecka J (2005) Extensively cystic renal neoplasms in adults (Bosniak classification II or III)–possible “common” histological diagnoses: multilocular cystic renal cell carcinoma, cystic nephroma, and mixed epithelial and stromal tumor of the kidney. Int Urol Nephrol 37:743–750
Volpe A, Finelli A, Gill IS, Jewett MA, Martignoni G, Polascik TJ, Remzi M, Uzzo RG (2012) Rationale for percutaneous biopsy and histologic characterisation of renal tumours. Eur Urol 62:491–504
Hora M, Urge T, Eret V, Stransky P, Klecka J, Kreuzberg B, Ferda J, Hyrsl L, Breza J, Holeckova P, Mego M, Michal M, Petersson F, Hes O (2011) Tubulocystic renal carcinoma: a clinical perspective. World J Urol 29:349–354
Braunagel M, Graser A, Reiser M, Notohamiprodjo M (2013) The role of functional imaging in the era of targeted therapy of renal cell carcinoma. World J Urol. doi:10.1007/s00345-00013-01074-00347
Siracusano S, Bertolotto M, Ciciliato S, Valentino M, Liguori G, Visalli F (2011) The current role of contrast-enhanced ultrasound (CEUS) imaging in the evaluation of renal pathology. World J Urol 29:633–638
Klatte T, Shariat SF, Remzi M (2013) Systematic review and meta-analysis of perioperative and oncological outcomes of laparoscopic cryoablation versus laparoscopic partial nephrectomy for the treatment of small renal tumors. J Urol. doi:10.1016/j.juro.2013.1011.1006
Conflict of interest
The authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Weibl, P., Hora, M., Kollarik, B. et al. Management, pathology and outcomes of Bosniak category IIF and III cystic renal lesions. World J Urol 33, 295–300 (2015). https://doi.org/10.1007/s00345-014-1301-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-014-1301-x